TELA — TELA Bio, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1561921 ·
Last close
$0.70
Market Cap
$31.43M
52W High
$1.00
52W Low
$0.60
ADV30
199,589
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 19,059,000 | 12,520,000 | -10,526,000 | -12,273,000 | 69,891,000 | 39,541,000 | 75,092,000 |
| Dec 2025 | 20,869,000 | 13,755,000 | -6,648,000 | -9,041,000 | 81,418,000 | 50,845,000 | 75,105,000 |
| Sep 2025 | 20,689,000 | 13,969,000 | -7,554,000 | -8,603,000 | 61,587,000 | 29,713,000 | 60,030,000 |
| Jun 2025 | 20,197,000 | 14,105,000 | -9,081,000 | -9,923,000 | 67,537,000 | 34,977,000 | 58,353,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-29,664,000
Investing CF
$898,000
Financing CF
$25,568,000
CapEx
$-535,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.79
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-409,834,000
Inventory
$12,213,000
Receivables
$9,715,000
ST Investments
—
EBIT TTM
$-33,523,000
Pretax Income TTM
$-39,602,000
Interest Exp TTM
$6,079,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$79,908,000
EBITDA
$-33,008,000
Free Cash Flow
$-17,713,250
Enterprise Value
$58,918,328
Total Cash
$30,424,000
Total Debt
$57,916,000
Shares Out
44,894,757
Trailing EPS
$-0.82
Book Value
$-0.35
ROE
-616.6%
ROA
-33.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 80,275,000 | -33,755,000 | -38,831,000 | 81,418,000 | 75,105,000 | — | -28,219,000 |
| Dec 2024 | 69,300,000 | -41,695,000 | -37,841,000 | 86,570,000 | 58,112,000 | — | -41,595,000 |
| Dec 2023 | 58,453,000 | -44,075,000 | -46,664,000 | 78,048,000 | 59,167,000 | — | -40,857,000 |
| Dec 2022 | 41,418,000 | -39,007,000 | -44,296,000 | 67,855,000 | 53,550,000 | — | -40,748,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.52
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ARAY | ACCURAY INC | $31.78M | $0.27 | — |
| MODD | Modular Medical, Inc. | $30.89M | $3.79 | — |
| BEAT | HeartBeam, Inc. | $28.34M | $0.50 | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $27.74M | $0.90 | — |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | $26.71M | $1.52 | — |
News headlines (Yahoo Finance, 1h cache)
TELA Bio (TELA) Q2 2026 Earnings Call Transcript
2026-08-19 13:01 · Yahoo
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...
2026-08-11 05:03 · Yahoo
TELA Bio Reports Second Quarter 2026 Financial Results
2026-08-10 20:05 · Yahoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-05 20:05 · Yahoo
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-29 20:05 · Yahoo
TELA Bio to Announce Second Quarter 2026 Financial Results
2026-07-20 20:05 · Yahoo
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25
2026-05-15 12:11 · Yahoo
TELA Bio, Inc. Q1 2026 Earnings Call Summary
2026-05-13 12:30 · Yahoo
TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...
2026-05-13 05:01 · Yahoo
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates
2026-05-12 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.